5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.86▲ | 1.86▲ | 1.86▲ | 1.87▼ | 1.89▼ |
MA10 | 1.88▼ | 1.88▼ | 1.89▼ | 1.92▼ | 1.67▲ |
MA20 | 1.93▼ | 1.96▼ | 1.97▼ | 1.88▼ | 1.60▲ |
MA50 | 2.00▼ | 1.94▼ | 1.92▼ | 1.66▲ | 3.41▼ |
MA100 | 1.92▼ | 1.77▲ | 1.72▲ | 1.58▲ | N/A |
MA200 | 1.73▲ | 1.68▲ | 1.65▲ | 3.11▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.015▼ | -0.020▼ | -0.022▼ | 0.240▲ |
RSI | 41.271▼ | 42.981▼ | 43.906▼ | 53.858▲ | 43.116▼ |
STOCH | 8.756▼ | 6.375▼ | 13.482▼ | 20.746 | 66.656 |
WILL %R | -83.871▼ | -83.871▼ | -87.179▼ | -74.074 | -33.708 |
CCI | -36.171 | -46.075 | -56.200 | -68.434 | 100.457▲ |
Monday, September 29, 2025 05:00 PM
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has appointed Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer, bringing on a seasoned financial leader to guide the company through ...
|
Monday, September 29, 2025 05:00 PM
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has appointed Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer, bringing on a seasoned financial leader to guide the company through ...
|
Thursday, September 25, 2025 04:55 AM
Clinical drug platform company Annovis Bio (NYSE:ANVS) announced on Thursday the appointment of Mark Guerin as CFO. Guerin has previously served at Onconova Therapeutics (TRAW), now known as Traws ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 1.88 | 1.89 | 1.82 | 1.85 | 39,067 |
29/09/25 | 1.97 | 1.97 | 1.86 | 1.89 | 18,819 |
26/09/25 | 1.88 | 1.89 | 1.8212 | 1.85 | 30,398 |
25/09/25 | 1.84 | 1.88 | 1.83 | 1.88 | 29,165 |
24/09/25 | 1.86 | 1.92 | 1.833 | 1.86 | 56,010 |
23/09/25 | 1.91 | 1.96 | 1.85 | 1.88 | 52,732 |
22/09/25 | 2.03 | 2.03 | 1.88 | 1.91 | 82,511 |
19/09/25 | 2.08 | 2.094 | 1.98 | 2.03 | 118,495 |
18/09/25 | 2.02 | 2.13 | 2.0065 | 2.06 | 96,647 |
17/09/25 | 2.00 | 2.04 | 1.98 | 1.99 | 56,246 |
|
|
||||
|
|
||||
|
|